Optomed Oyj
HLSE:OPTOMED
5.61
0.00€ (0.00%)
5.61
0.00€ (0.00%)
End-of-day quote: 05/18/2024

Optomed Oyj financials at a glance

The revenue of Optomed Oyj is reported as 0.0151 billion Euro in the fiscal year 2023. The earnings were -0.25 Euro per share in 2023, which was 32.43 higher than 2022. And about -0.00088 billion Euro are reported as free cash flow in the financials of Optomed Oyj 2023. No dividends were paid to the shareholders of the Optomed Oyj stock HLSE:OPTOMED in the financial year 2023.

15.10€M
Revenue
-0.25€
Earnings Per Share
67.83%
Gross Margin %
-0.30€M
Free Cash Flow
Revenue
15.10
Earnings Per Share
-0.25
Gross Margin %
67.83
Free Cash Flow
-0.30

Financials

Year Year TTM 2023 2022 2021 2020
Rev. Revenue N/A 15.10€M 14.66€M 14.85€M 13.01€M
GM % Gross Margin % 68.33% 67.83% 62.83% 66.26% 68.01%
OM Operating Margin -16.28% -26.18% -33.41% -31.39% -20.85%
EPS Earnings Per Share -0.27€ -0.25€ -0.37€ -0.32€ -0.24€
Div. Dividends N/A 0.00€ 0.00€ 0.00€ 0.00€
PR % Payout Ratio % 0 -0.00% -0.00% -0.00% -0.00%
Sha. Shares N/AM 17.78M 16.17M 13.58M 13.26M
OCF Operating Cash Flow N/A -0.62€M -2.37€M -2.94€M -2.80€M
FCF Free Cash Flow N/A -0.30€M -5.40€M -3.40€M -3.07€M
FCFS Free Cash Flow Per Share -0.17€ -0.18€ -0.37€ -0.41€ -0.35€